References

Filters: Author is Papaluca, T  [Clear All Filters]
P
Papaluca T, Roberts SK, SI S, et al. Efficacy and Safety of Sofosbuvir/Velpatasvir/Voxilaprevir for Hepatitis C Virus (HCV) NS5A-Inhibitor Experienced Patients With Difficult to Cure Characteristics. Clin Infect Dis. 2021;73(9):e3288-e3295. doi:10.1093/cid/ciaa1318.
Papaluca T, Roberts SK, Strasser SI, et al. Efficacy and safety of sofosbuvir/velpatasvir/voxilaprevir for HCV NS5A-inhibitor experienced patients with difficult to cure characteristics. Clin Infect Dis. 2020:ciaa1318. Online ahead if print. doi:10.1093/cid/ciaa1318.
Top